Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Isoniazid for TBM in Rapid Acetylators
NCT03787940Unknown
- Sponsor
- Beijing Chest Hospital
- Start
- Mar 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of isoniazid in tuberculous meningitis (TBM) (3 arms), sponsored by Beijing Chest Hospital. Primary endpoint: Number of Participants with death or severe disability at 12 months. Status: unknown.
02
Drugs
isoniazid
03
Conditions
tuberculous meningitis (TBM)
Beyond the preview
Go deeper on NCT03787940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03787940.